RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • AbbVie-Shire deal puts more pressure on Congress to overhaul tax code

    A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings. Illinois drug maker AbbVie Inc. said Friday that it...
  • AbbVie to buy drugmaker Shire for $55 billion

     AbbVie to buy drugmaker Shire for $55 billion
    AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom. The deal, announced by both companies in a...
  • Capital BlueCross banned from enrolling new Medicare members

    Capital BlueCross banned from enrolling new Medicare members
    Federal authorities have banned Capital BlueCross from enrolling new customers into its Medicare plans, saying the health insurance company denied some seniors coverage for emergency services and access to prescription drugs, and overcharged about 3,000...
  • AbbVie says hepatitis C regimen gets nod for FDA priority review

    AbbVie says hepatitis C regimen gets nod for FDA priority review
    U.S. regulators have granted priority review for AbbVie Inc's experimental all-oral regimen for patients infected with the most common genotype of hepatitis C virus, the company said on Friday. The priority review means the Food and Drug...
  • This is a civilized society? Three face possible executions this week.

    This is a civilized society? Three face possible executions this week.
    In the first executions since Oklahoma in effect tortured a condemned man to death last month, three convicted killers face death by lethal injection this week in cases that reflect the barbaric absurdity of the practice. The first man slated for the...
  • A better way to cure what ails us

     A better way to cure what ails us
    Annual spending on healthcare in America totals nearly $9,000 per person, accounting for more than 17% of the U.S. economy. Yet, on some of the most basic medical interventions, we're failing. Sometimes patients are overtreated, particularly with...
  • Allergan employees, Irvine officials worried over Valeant offer

    Allergan employees, Irvine officials worried over Valeant offer
    Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
  • Pharmacist is facing disciplinary action by state regulators

    Pharmacist is facing disciplinary action by state regulators
    A pharmacist with drugstores in Glendale and West Hills is "a danger to the public health and safety" for allegedly possessing counterfeit and expired prescription medications, state regulators contend. As part of disciplinary proceedings, the...
  • Allergan urges shareholders to reject Valeant buyout offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. said last week that it will take its acquisition offer directly to...
  • Allergan urges shareholders to reject Valeant offer

    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
  • Abbott to buy Russian drug maker

    Abbott to buy Russian drug maker
    Abbott Laboratories said Monday it has agreed to acquire a Russian pharmaceutical manufacturer for between $395 million and $495 million in cash plus the assumption of about $136 million in debt. The Lake County-based medical products company will...